Head-to-head · WeighScore
eMI Aesthetics vs Maven Clinic
The verdict
eMI Aesthetics takes it — 70.1/100 to 58/100.
eMI Aesthetics grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. eMI Aesthetics is a US direct-to-consumer telehealth brand offering doctor-guided GLP-1 weight loss programs to eligible patients in all 50 states.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | eMI Aesthetics | Maven Clinic |
|---|---|---|
| WeighScore | 70.1/100 | 58/100 |
| Grade | C | C |
| Scorecard rank | #110 | #383 |
| Semaglutide | $179/mo (all doses, compounded) | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #110 · C
Strengths
- Available to eligible patients in all 50 states
- Offers both semaglutide and tirzepatide, plus an oral semaglutide option
- Intake and provider visits run through OpenLoop Health, an established telehealth network
Where it loses points
- Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
- No fill pharmacy or named medical director is publicly listed
- Support appears limited to email, with no phone number or hours published
Graded #383 · C
Strengths
- Dedicated GLP-1 Care program with brand-name (FDA-approved) GLP-1 prescriptions
- On-demand visits with metabolic and hormone-health specialists, plus nutrition and strength support
- Integrated with broader women's, hormone, and family health care
- LegitScript-verified; trusted by 2,300+ employers
- Available as both an employer health benefit and a consumer self-pay option
Where it loses points
- Pricing is not published on the public site
- Primarily distributed through employers and health plans — direct access can depend on your plan
- US state availability for GLP-1 is not specified publicly
- Brand-name only — no lower-cost compounded option
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.